Collaborating with Pfizer to identify cancer biomarkers: spotlighting our artificial intelligence (AI) andinformatics capabilities
Our Informatics and Data Science team has developed a paper, in collaboration with authors from Pfizer, that details a novel approach to identifying emerging cancer biomarkers. The paper, recently published in the journal Cancer Informatics, is accompanied by a publicly accessible, interactive dashboard to allow users to explore new insights around emerging biomarkers.